购物车
- 全部删除
- 您的购物车当前为空
Fexinidazole (HOE 239) 是具有口服活性的硝基咪唑抗锥虫药物。它显示出对布鲁氏杆菌亚种和菌株的杀锥虫活性,IC50值为 0.7-3.3 μM (0.2-0.9 μg/ml)。它具有用于因感染布鲁氏菌引起的人类昏睡病的潜力。
为众多的药物研发团队赋能,
让新药发现更简单!
Fexinidazole (HOE 239) 是具有口服活性的硝基咪唑抗锥虫药物。它显示出对布鲁氏杆菌亚种和菌株的杀锥虫活性,IC50值为 0.7-3.3 μM (0.2-0.9 μg/ml)。它具有用于因感染布鲁氏菌引起的人类昏睡病的潜力。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥ 108 | 现货 | |
25 mg | ¥ 159 | 现货 | |
50 mg | ¥ 223 | 现货 | |
100 mg | ¥ 347 | 现货 | |
500 mg | ¥ 798 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 141 | 现货 |
产品描述 | Fexinidazole (HOE 239) is an antiparasitic agent. It has activity against Trypanosoma cruzi, Tritrichomonas foetus, Trichomonas vaginalis, Entamoeba histolytica, Trypanosoma brucei, and Leishmania donovani. The biologically relevant active metabolites in vivo are the sulfoxide and sulfone. |
激酶实验 | Promoter-luciferase reporter assay: A 2,767-bp sequence of human survivin gene promoter is isolated from human genomic DNA by PCR using Pyrobest polymerase and the following primers: 5 |
别名 | 非昔硝唑, HOE 239 |
分子量 | 279.31 |
分子式 | C12H13N3O3S |
CAS No. | 59729-37-2 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 50 mg/mL (179.01 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.